Conferences  >  Medicine & Healthcare  >  Oncology

Miami Cancer Institute

The Miami Brain Symposium will focus on state-of-the-art approaches to the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions. This symposium will engage participants as the expert faculty navigate through complex cases, novel treatment strategies, and panel discussions.

Phone: [786-596-1285];     Email: eleanora@baptisthealth.net

Oncology, Brain tumor, Symposium, Medical Symposium, continuing medical education,

Continuing Medical Education (CME),    Continuing Medical Education (CME)

European Society of Head and Neck Radiology – ESHNR

The content of the 2024 Masterclass will focus more on the skull base region. This meeting will explore refresher and challenging areas with particular reference to upper aerodigestive tract, soft tissue neck, oncology and neck glands. The programme will include short lectures highlighting recent developments, imaging techniques, relevant anatomy and pathology, followed by case-based discussion in small-group workshops giving you the opportunity to ask questions and receive feedback. Aimed at Radiologists with an interest in, and experience of, head and neck radiology, this course will help all those who wish to brush-up on their anatomy, learn about latest developments and add value and structure to their imaging reports.

Phone: [+43 1 5334064-918];     Email: office@eshnr.eu

upper aerodigestive tract, soft tissue neck, oncology, neck glands, skull base, head and neck, radiology

Radiology, Nuclear Medicine and Radiation Therapy,    Continuing Medical Education (CME)

The European Association for Cancer Research (EACR)

This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.

Conference Officer: Chris Iliffe;     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances

ESMO - European Society for Medical Oncology

ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

ESMO Asia 2024 Secretariat;     Email: asiacongress@esmo.org

oncology, translational research, clinical trials, breast cancer, CNS, precision medicine, gastrointestinal tumours, genitourinary tumours, gynecological tumours, haemathological malignancies, head and neck cancers, immunotherapy, melanoma, sarcoma, rare tumours, thoracic cancer, supportive care, palliative care, Clinical Practice Guidelines, radiology

Translational Medicine, Clinical Trials,    Continuing Medical Education (CME)

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Seattle is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications. Focusing on a multidisciplinary approach, the event aims to integrate new advancements into patient-centered care. Designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other professionals, attendees will engage with colleagues and experts to critically evaluate data and improve patient outcomes.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

seattle, binaytara foundation, hematology, breast cancer, CME, CME accredited, oncology, cancer

Continuing Medical Education (CME),    Hematology

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025, Phoenix conference in Scottsdale, AZ is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications. Focusing on a multidisciplinary approach, the event aims to integrate new advancements into patient-centered care. Designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other professionals, attendees will engage with colleagues and experts to critically evaluate data and improve patient outcomes.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

hematology, oncology, breast cancer, phoenix, CME

Binaytara Foundation

The expert faculty will present a comprehensive overview of recent updates in hematology and oncology. The program will feature in-depth discussions and analyses of the latest scientific discoveries and advancements. Faculty will contextualize these findings within clinical practice and explore their potential to alter current standards of care. This conference is designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals, providing them with the latest updates in the field. Emphasizing a multidisciplinary approach, it will showcase the integration of new advancements into patient-centered care.

Binaytara Foundation;     Phone: [cme@binayfoundation.org];     Email: cme@binayfoundation.org

oncology, hematology, cancer

event lab. GmbH

In kompakter und anschaulicher Form fassen ExpertInnen der Universitätsklinik Leipzig und der Universitätsklinik Jena in 4 Stunden die interessantesten Erkenntnisse des Kongresses der American Society of Hematology zusammen und stehen anschließend zur Diskussion bereit. Die Registrierung ist kostenfrei. Die Veranstaltung ist Teil der Veranstaltungsreihe "Hämatologie Leipzig" der Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie des Universitätsklinikums Leipzig. Weitere geplante Veranstaltungen unter: https://leipzig-haematologie.de/

Kongressbüro der event lab. GmbH;     Phone: [+49 341 308884 64];     Email: haematologie-leipzig@eventlab.org

Hämatologie, Onkologie, American Society of Hematologie

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Portland is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Phone: [cme@binayfoundation.org];     Email: cme@binayfoundation.org

oncology, hematology, breast cancer, cancer, CME

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Houston is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Phone: [cme@binayfoundation.org];     Email: cme@binayfoundation.org

oncology, hematology, breast cancer, CME

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Augusta is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, breast cancer, CME

The European Association for Cancer Research (EACR), in conjunction withAstraZeneca

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, circulating tumour DNA, cell-free DNA, liquid biopsy, early cancer detection, clinical trial design, breast cancer, lung cancer, colorectal cancer, bladder cancer, virtual cancer research conference

Binaytara Foundation

The Best of Hematology 2025 conference in Albuquerque is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology. Drawing insights from the 66th ASH Annual Meeting (ASH24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, CME

Abcam

This two-day academic conference owill bring together researchers to explore the complex interactions between metabolic reprogramming and cancer biology. This event aims to foster collaboration and inspire new approaches in cancer research and treatment. The conference will feature sessions on four critical topics: host-tumor interaction, immunometabolism & tumor microenvironment, tumor initiation, therapy & progression, and diet & nutrient transporters. Short talk and poster presentation opportunities are available for in-person attendees. Visit the website for more information.

Abcam Events;     Email: events@abcam.com

cancer, metabolism, immunometabolism, tumor microenvironment, host-tumor interaction, diet transporters, cancer biology, metabolic reprogramming

The European Association for Cancer Research and Boehringer Ingelheim

We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies.

Email: christopher.iliffe@eacr.org

cancer research, oncology, MAPK pathway, small molecule inhibitors, intrinsic resistance, adaptive resistance, effective cancer therapy agents, pan-RAS inhibitors, gene regulation, target validation, drug development, clinical and translational opportunities, rational combination therapies, cross-resistance to immune modulators

Molecular Biology,    Pharmacology and Drug Development

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Boise is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, CME, Breast Cancer

Binaytara Foundation

The Hawaii Gastrointestinal Cancers Summit is a CME-accredited event that brings together leading experts in gastrointestinal malignancies to provide a comprehensive review of current and emerging strategies for managing cancers of the gastrointestinal tract. This summit is designed to enhance participants' knowledge and competence in applying the latest practice-changing clinical data and expert recommendations to improve patient outcomes. The program will include in-depth discussions and analyses of the latest scientific advancements and key updates in gastrointestinal cancers, including gastroesophageal, hepatobiliary, pancreatic, neuroendocrine, and colorectal cancers. Expert faculty will contextualize the use of various therapeutic agents, exploring how to effectively integrate these treatments into patient care. Additionally, case presentations will be featured to address the management of complex and challenging cases.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, cancer, gastrointestinal cancer, CME

The European Association for Cancer Research (EACR)

This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism

Biology,    Immunology and Allergic Diseases

event lab. GmbH

The event will cover malignant and inflammatory pancreatic diseases, featuring presentations from international experts and junior researchers. It offers workshops, poster sessions, and opportunities for networking and collaboration.

A fee-based registration is required and can be made under the following link: https://eventlab.regasus.de/portal/standard/registration/personal

Conference office event lab. GmbH;     Phone: [+49 (0)341 30 88 84-82];     Email: KBornschein@eventlab.org

pancreatitis, endoscopy. pancreatitis surgery, pancreatic cystic lesions, neuroendocrine tumors

Gastroenterology,    Hepatology

Deutsche Krebsgesellschaft und Deutsche Krebshilfe

The AEK Cancer Congress hosts around 500 participants. It is funded by the German Cancer Society and the German Cancer Aid and will be held in 2025 under the theme “Understanding and targeting metastatic cancer”. You will see that we have assembled a great line-up of outstanding speakers, who will cover multiple exciting topics of current biology, from basic mechanism to multi-omics approaches and new molecular and immune-therapies to overcome metastatic cancer disease.

Kongress- und Kulturmanagement GmbH - Frau Frederike Stumpf;     Email: frederike.stumpf@kukm.de

Molecular Biology,    Stem-cell Research & Therapy

Infonet

4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia, USA during March 06- 08, 2025. iCancer Conference 2025 has a theme "Innovations in Cancer Research".

Phone: [06172752612];     Email: jessie@icancerconference.org

Keywords: Conference, Cancer, oncology, Oncology - Medical, oncology meetings, Cancer Conference, Philadelphia, Breast cancer conference Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy,

event lab. GmbH

Renommierte Experten aus ganz Deutschland präsentieren Neuigkeiten aus der Forschung, Diagnostik und Therapie der Hämatologie. Am Freitagabend erwartet die Teilnehmer ein spannender Überraschungsvortrag. Neben zahlreichen Vorträgen bietet die Veranstaltung auch Raum für anregende Diskussionen und den Austausch von Erfahrungen unter Kolleginnen und Kollegen. Die Veranstaltung ist Teil der Veranstaltungsreihe "Hämatologie Leipzig" der Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie des Universitätsklinikums Leipzig.

Kongressbüro der event lab. GmbH;     Phone: [+49 341 308884 64];     Email: haematologie-leipzig@eventlab.org

Infektiologie, Immuntherapie, Gentherapie

Hematology,    Immunology and Allergic Diseases

Verein fuer Leukaemieforschung und -Therapie e.V. Muenster together with Klinikum Großhadern, Munich,Germany

The symposium is taking place again in Munich, Germany, in-person from Sunday, March 16 until Wednesday, March 19, 2025. Additionally to the XI Main Sessions two free contributions sessions MS V (Poster session) and MS IX (Best of Free Contributions Session) will additionally deliver the possibility to all those who want to present their own research data in form of a free contribution and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias. We therefore encourage all who are interested in actively participating in ISALXIX with a free contribution to submit their abstract(s). All accepted abstracts will be part of the open access ISALXIX supplement published in ANNALS OF HEMATOLOGY and in the Poster Viewing and Discussion Session (MSV). Abstract Submission Deadline: October 31, 2024.

Organizing Office Beate Buske-Kosel;     Phone: [+49 160 615 1531];     Email: info@acute-leukemias.de

MS I: Biology of Acute Leukemias MS II: Biology in Acute Leukemias MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis MS IV: Novel Approaches and Targeted Therapies in AML MS VI: Risk adapted Therapy of AML MS VII: Biology and Treatment of APL MS VIII: MRD in Acute Leukemias: Methods and Clinical Applications MS X: Immunotherapy for Acute Leukemias MS XI: ALL: Biology and Treatment Strategies

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Pharmacology and Drug Development,    Molecular Biology

ESMO - European Society for Medical Oncology

The ESMO Sarcoma and Rare Cancers Congress 2025 promises to be an excellent platform for the exchange of cutting-edge research, innovative therapeutic approaches, and collaborative discussions aimed at advancing this field of oncology. Mark your calendars for 20 – 22 March 2025, as we converge in the picturesque city of Lugano, Switzerland, renowned for its scenic beauty and vibrant culture. The ESMO Sarcoma and Rare Cancers Congress 2025 scientific and educational programme will delve into the latest developments in diagnosis, treatment modalities, biology, and molecular classification of rare solid tumours, offering attendees a comprehensive overview of the rapidly evolving landscape in this specialised area.

Meetings Operations team;     Phone: [+41 91 97 31 946];     Email: meetings@esmo.org

sarcoma, rare cancers, oncology, cancer treatment, precision medicine, immunotherapy, soft tissue sarcomas, bone sarcomas, clinical trials, multidisciplinary care, cancer research, pediatric oncology, advanced therapies, targeted therapy, patient care, innovative treatments, rare tumors, genetic profiling, cancer biomarkers, molecular oncology, survivorship, personalised medicine, global oncology, treatment guidelines, research collaborations, healthcare professionals, drug development, radiation oncology, surgical oncology

Biology,    Molecular Biology

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Des Moines is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, breast cancer, CME

Binaytara Foundation

The 2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy is a CME-accredited, in-person hematology conference featuring leading hematology experts. Expert faculty will place recent updates into clinical context and discuss how the results may change the current standards of care for patients with benign and malignant hematologic disorders. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, CME, cellular therapy, hematologic malignancies

The European Cancer and Oncology Congress, scheduled for April 14-15, 2025, in Rome, Italy, promises to be a pivotal event for professionals dedicated to advancing cancer research and treatment across Europe and beyond. This congress serves as a crucial platform for oncologists, researchers, clinicians, nurses, and allied healthcare professionals to exchange ideas, present cutting-edge research findings, and discuss the latest innovations in cancer diagnosis, treatment, and care.

Email: cancer@c2presearch.com

Cancer, Oncology, Psycho-Oncology, Cancer Genomics and Epigenetics, Cancer Immunotherapy, Cancer Drug Market

Binaytara Foundation

The Summit on Cancer Health Disparities 2025 (SCHD25) is a premier annual event focused on addressing cancer health disparities. The conference serves to bridge research and practice, offering practical strategies to improve cancer care delivery and outcomes. SCHD25 will unite oncology professionals, researchers, policymakers, and other stakeholders looking to address factors contributing to cancer health disparities with evidence-based interventions..

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, public health, cancer, cancer disparities, health disparities

Binaytara Foundation

The Alaska Hematology Oncology Conference is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with hematology and oncology experts. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in precision-guided management in hematology and oncology. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Binaytara Foundation CME;     Email: cme@binayfoundation.org

oncology, hematology, cancer, CME

The European Association for Cancer Research (EACR)

One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.

European Molecular Biology Organization (EMBO)

The i-Cancer Congress is a premier international event scheduled to take place in Toronto, Canada on May 26-27, 2025. This congress brings together leading experts, researchers, healthcare professionals, and industry leaders in the field of oncology to discuss and share the latest advancements in cancer research, treatment, and care. The i-Cancer Congress offers an unparalleled opportunity to stay updated on the latest trends and developments in oncology. Attendees will benefit from educational sessions, networking opportunities, and exposure to innovative solutions and technologies shaping the future of cancer treatment. This event is designed to enhance knowledge, foster collaboration, and inspire new approaches to combat cancer.

Phone: [02032898567];     Email: info@icancercongress.com

Cancer Research, Immunotherapy, Oncology, Clinical Research, Lung Cancer, Breast Health, Cancer Prevention and Early Detection, Supporting Cancer Patients and Survivors, Clinical Studies, Cancer Immunity and Immunotherapy, Precision Medicine and Cancer Treatment, Gynaecologic Cancer, Neuro-Oncology and Neurosurgical Oncologys

Kongress- und Kulturmanagement GmbH

Inter- und multidisziplinäre Diagnostik und Therapie im gesamten Bereich der gastrointestinalen Onkologie. Am Vortag: Masterclass für junge Kollegen: Ein Teilbereich der GI Onkologie wird anhand eines Falls von allen Seiten beleuchtet (Vortrag und Diskussion)

Phone: [01520 3132647];     Email: davida.drescher@konzeptext.de

Surgery,    Radiology, Nuclear Medicine and Radiation Therapy

Deutsche Gesellschaft für Radioonkologie e.V.

Der DEGRO 2025 richtet sich an Radioonkologen, Medizinphysiker, Strahlenbiologen, MTRAs und Studierende. Unter dem Motto „RADIOONKOLOGIE | TEAMWORK – Maßgeschneidert. Patientenzentriert. Zukunftsorientiert. Selbstbestimmt im Team“ liegt der Fokus auf der interdisziplinären Zusammenarbeit. Abstracts können eingereicht werden. Es werden Refresherkurse sowie Kurse zur Strahlenschutzverordnung angeboten. Weitere Themen: maßgeschneiderte Therapien und patientenzentrierte Ansätze.

Kongressorganisation;     Phone: [+49 3643 2468-126];     Email: degro-registrierung@kukm.de

Radioonkologie, Strahlentherapie, Nuklearmedizin, Medizinphysik, Strahlenbiologie, MTRAs, Strahlenschutzverordnung, interdisziplinäre Zusammenarbeit, Abstract-Einreichung, Refresherkurse

Radiology, Nuclear Medicine and Radiation Therapy,    Training in Radiation Protection

Spectus meetings World

We are delighted to extend a warm greeting for the 2nd International Conference on Cancer and Oncology Research, (World Cancer 2025 ) which will be held in the famous city Barcelona, Spain on June 23-24, 2025, organized in coordination with generous support and cooperation from passionate academicians and organizing committee members with the theme “Raising Wings to Promote Cancer Free World".

Phone: [1 302 308 5943];     Email: worldcancer@spectusconferences.com

Conference Sessions Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Cancer Imaging Techniques Radiation Oncology Gynecologic Cancer Cancer treatment & palliative care Pediatric Oncology Cancer Immunology & Immunotherapy Breast cancer Computational Analysis of Cancer Nanopore Sequencing of Cancer Genomes Biomarkers in Cancer Organ-Defined Cancers The Application of Clinical Proteomics for Precision Oncology Drug Resistance in Cancer Cancer Genetics and Epigenetics Cancer Diagnostics: From Research to Clinical Practice Advanced Therapies in Cancer Cancer Diagnosis and Screening Cancer Science and Targeted Therapies Cancer Science and Therapeutics Organ Specific Cancer Pharmacology in Cancer AI in Cancer Control Tobacco control Cancer diagnosis and care

Uniklinik Köln

After the great success of the 2nd Cologne Conference on Lung Cancer in 2019 we are again looking forward to an exciting meeting on cutting-edge translational research in lung cancer. At the conference, the world's best lung cancer researchers will discuss the current challenges in the diagnosis and treatment of lung cancer. Topics include early detection & prevention of lung cancer, intrinsic & extrinsic influences on tumor evolution, drug resistance & plasticity, next generation immunotherapy, mechanisms of metastasis, tumor-neuronal interactions, liquid biopsies and late breaking clinical trials update.

When: 26 & 27. June 2025

Email: a.breuer@uni-koeln.de

lungcancer

Fusion

Laura Trundle, Director;     Email: laura@fusion-conferences.com

DNA Damage Response, cancer biology, replication stress, cancer therapies, PARP inhibitors, BRCA, clinical development

Molecular Biology,    Genomics and Bioinformatics

Kongress- und Kulturmanagement GmbH

Der Kongress verspricht ein wissenschaftlich anspruchsvolles und interaktives Programm, das sämtliche Aspekte der Schlaganfallversorgung von der prästationären Phase bis zur Rehabilitation umfasst. Besonderen Wert wird daraufgelegt, alle in der Schlaganfallversorgung involvierten Fachdisziplinen zu repräsentieren und die neuesten Entwicklungen in der Schlaganfalltherapie zu präsentieren.

Kongress- und Kulturmanagement GmbH - Frau Svantje Hopf;     Email: dsg-kongress@kukm.de

The European Association for Cancer Research (EACR)

The 6th edition of this conference will focus on cancer models that span in vitro investigations to in vivo cancer biology. It will emphasise how targeting the mechanisms that control tissue assembly – including the interactions with multiple epithelial cell types and the immune system – affects cancer progression and treatment response. Emerging topics also being discussed include mechanobiology, the immune response, how the extracellular matrix controls cell architecture, and how cell fate transitions underpin tissue morphogenesis and the metastatic cascade. The target audience for this conference is scientists, postdocs, and graduate students interested in the latest generation of engineered ex vivo models of tissue biology, in vivo cancer biology, and the use of these mechanobiological concepts for the development of cancer therapeutics. It will also be highly relevant for industry scientists interested in cutting-edge models of cancer and journal editors interested in ex vivo to in vivo models of biology and cancer.

Conference Officer Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, in vitro models of cancer, ex vivo models of cancer, in vivo models of cancer, the extracellular matrix, cancer cell architecture, mechanobiology, immune response to cancer, tissue morphogenesis, the metastatic cascade, cancer immunotherapies, advanced imaging technologies, organoids, microtissue platforms, spatial transcriptomics, cell fate transitions, homeostasis, cancer progression, cancer therapeutic developments.

Molecular Biology,    Immunology and Allergic Diseases

Nexovo Group

We are thrilled to invite you to the International Research Conference on Nursing & Healthcare, organized by Nexovo Group, set to take place on September 25-26, 2025, in the dynamic city of Dubai, UAE.

Nexovo Nursing 2025 will be a premier event designed to unite professionals, researchers, and thought leaders to delve into the latest developments and innovations in nursing and healthcare.

Phone: [+91-8688033511];     Email: Nursing@nexovoconferences.com

EMBL Heidelberg

This meeting will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. We aim to bring together scientists from across several disciplines connected with cancer research, for a unique opportunity to interact and stimulate further integration of these efforts.

EMBL Events;     Email: events@embl.de